COMPANY LTD NEXTGEN has a total of 15 patent applications. Its first patent ever was published in 2015. It filed its patents most often in Canada, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN, CYTOTHERAPEUTICS INC and PROCHON BIOTECH LTD.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Sugars | |
#6 | Additive manufacturing | |
#7 | Implantable devices | |
#8 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Deev Roman Vadimovich | 7 |
#2 | Isaev Artur Aleksandrovich | 7 |
#3 | Bozo Ilya Yadigerovich | 7 |
#4 | Bogov Andrei Alekseevich | 4 |
#5 | Salafutdinov Ilnur Ildusovich | 4 |
#6 | Plaksa Igor Leonidovich | 4 |
#7 | Masgutov Ruslan Faridovich | 4 |
#8 | Kiselev Sergey Lvovich | 4 |
#9 | Bogov Aleksei Andreevich | 4 |
#10 | Rizvanov Albert Anatolyevich | 4 |
Publication | Filing date | Title |
---|---|---|
BR112017023058A2 | optimized nucleotide sequence and pharmaceutical composition based on this sequence with extended vegf transgene expression | |
CN106488771A | For regenerating the generation method of the personalized gene activation implant of bone tissue |